Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: Effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production

Journal of Clinical Immunology

Volumn 18, Issue 2, 1998, Pages 124-131

  Al Harthi, Lena ^a   Roebuck, Kenneth A ^a   Landay, Alan ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AIDS; Human immunodeficiency virus; IL 15; Immune based therapy; Interleukin (IL) 12

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 7; MITOGENIC AGENT; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; REPORTER GENE; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANTIBODIES, VIRAL; CELL DIVISION; CELLS, CULTURED; CYTOKINES; DNA, VIRAL; HIV-1; HUMANS; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; REPETITIVE SEQUENCES, NUCLEIC ACID; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

EID: 0031910034     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023246800353     Document Type: Article

References (48)

1. Kobayashi N, Hamamoto Y, Koyanagi Y, et al.: Effects of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. Biochem Biophys Res Commun 165:715-721, 1989
2. Osborn L, Kunkel S, Nabel GJ: Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 86:2336-2340, 1989
3. Poli G, Bressler P, Kinter AL, et al.: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 172:151-158, 1990
4. Poli G, Kinter AL, Fauci AS: Interleukin 1 induces expression of human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: Inhibition of inductive effect by interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 9:108-112, 1989
5. Gendelman HE, Baca L, Turpin JA, Kalter DC, et al.: Restriction of HIV replication in infected T cells and monocytes by interferon-alpha. AIDS Res Hum Retrovirus 6:1045-1049, 1990
6. Meylan PR, Guatelli JC, Munis JR, Richman DD, Kornbluth RS: Mechanisms for the inhibition of interferons-alpha, -beta, and -gamma in primary human macrophages. Virology 1993:138-148, 1993
7. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature 389:529-334, 1996
8. Hober D, Haque A, Waltre P, et al.: Production of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS: Enhanced level of TNF-alpha is related to higher cytotoxic activity. Clin Exp Immunol 78:329-333, 1989
9. Trentin L, Garbsa S, Zambello R, et al.: Spontaneous production of IL-6 by alveolar macrophages from human immunodeficiency virus type 1 infected patients. J Infect Dis 166:731-737, 1992
10. Navikas V, Link J, Persson C, et al.: Increased mRNA expression of IL-6, IL-1, TNF-alpha, perform in blood mononuclear cells in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9:484-489, 1995
11. Lederman MM, Connick E, Landay A, et al.: Partial immune reconstitution after 12 weeks of HAART (AZT, 3TC, Ritonavir) preliminary results of ACTG 315. 4th Conference on Retroviruses and Opportunistic Infections. Washington, DC, Jan 1997, abstr LB13
12. Cameron DW, Heath-Chiozzi M, Kravick S, Mills R, Pathoff A, Henry D: Prolongation of life und prevention of AIDS complications in advanced HIV immunodeficiency with ritonavir: Update. Int Conf AIDS 1998, abstr Mo.B.411
13. Conners M, Kovacs JA, Krevat S, et al.: HIV infection induces changes in CD4+ T-cell phenotypes and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 3:533-540, 1997
14. Kelleher AD, Al-Harthi L, Landay A: Immunological effects of antiretroviral and immune therapies for HIV. AIDS 11 (Suppl A):S149-S155, 1997
15. Lane HC, Siegel JP, Rook AH, et al.: Use of interleukin-2 in patients with acquired immunodeficiency syndrome. J Biol Response Modif 3:512-516, 1984
16. Volberding P, Moody DJ, Beardslee, et al.: Therapy of acquired immune deficiency syndrome with recombinant Interleukin-2. AIDS Res Hum Retrovirus 3:115-124, 1987
17. Schwartz DH, Skowron G, Merigan TC: Safety and effects of interleukin-2 plus zidoviduine in asymptomatic individuals infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 4:11-23, 1991
18. Kovacs JA, Vogel S, Albert JM, et al.: Controlled trial of interleukin-2 infusions in patients with the human immunodeficiency virus. N Engl J Med 335:1350-1356, 1996
19. Clerici M, Lucey DR, Berzofsky JA, et al.: Restoration of HIV-1 specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721-1724, 1993
20. Landay AL, Clerici M, Hashemi F, et al.: In vitro T cell immune function in HIV+ individuals: Effects of IL-12 and anti-IL-10. J Infect Dis 173:1085-1091, 1996
21. Chechimi J, Marshall JD, Salvucci O, et al.: IL-15 enhances immune function during HIV infection. J Immunol 158:5978-5987, 1997
22. Bayard-McNeeley M, Doo H, He S, Hufner A, Johnson WD, Ho JL: Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro. Clin Diagn Lab Immunol 3:547-553, 1996
23. Akridge RE, Reed SG: Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells. J Infect Dis 173:559-564, 1996
24. Patki AH, Quinones-Mateu ME, Dorzaio D, Yen-Lieberman B, Boom WH, Thomas EK, Lederman MM: Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. J Clin Invest 98:616-621, 1996
25. Lucey DR, Pinto LA, Bethke FR, Rusnak J, Melcher GP, Hashemi FN, Landay AL, et al.: In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type-1 infected patients. Clin Diagn Lab Immunol 4:43-48, 1997
26. Finnegan A, Roebuck KA, Nakai BE, Gu DS, Rabbi MF, Song S, Landay AL: IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol 156:841-851, 1996
27. Smithgall MD, Wong JG, Critchett KE, Haffar OK: IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 156(6):2324-2330, 1996
28. Mehrotra PT, Grant AJ, Siegel JP: Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 154(10):5093-5102, 1995
29. Biswas P, Poli G, Kinter AL, et al.: Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbal myristate. J Exp Med 176(3):739-750, 1992
30. Rook AH, Masur H, Lane HC, et al.: Interleukin-2 enhances the depressed natural killer and cytomeglovirus-specific cytotoxic activity of lymphocytes from patients with the acquired immunodeficiency syndrome. J Clin Invest 72:398-403, 1983
31. Kinter AL, Bende SM, Hardy EC, Jacobson RJ, Fauci AS: Interleukin 2 induces CD8+ T cell mediated suppression in CD4+ T cells and this effect overrides its ability to stimulate virus expression. Proc Natl Acad Sci USA 92:10985-10989, 1995
32. Barker F, Mackowicx CK, Levy JA: Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 92:11135-11149, 1995
33. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, et al.: Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 91:118111-18115, 1994
34. Teppler H, Kaplan G, Smith K, et al.: Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune responses of patients with human immunodeficiency virus type 1 infection. J Infect Dis 167:291-298, 1993
35. Jacobson EL, Pillaro F, Smith A: Rational interleukin-2 therapy for HIV positive individuals: Daily low doses enhance immune function without cytotoxicity. Proc Natl Acad Sci USA 93:10405-10410, 1996
36. Kovacs J, Baseler M, Dewar RJ, et al.: Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection: A preliminary study. N Engl J Med 332:567-575, 1995
37. Davey RT, Chain DG, Piscitelli SC, et al.: Subcutaneous administration of interleukin-2 in human immunodeficiency virus type-1 infected patients. J Infect Dis 175:781-789, 1997
38. Grabstein KH, Eisenman J, Shanebeck K, et al.: Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-968, 1994
39. Seder RA, Grabstein KH, Berzofsky JA, McDyer JF: Cytokine interaction in human immunodeficiency virus-infected individuals: Roles of interleukin IL-2, IL-12, and IL-15. J Exp Med 182:1067-1078, 1995
40. Estaquire J, Idziorek T, Zou W, et al.: T helper type 1/T helper type 2 cytokines and T cell death: Effect of interleukin-12 on activation-induced CD95 (fas/apo-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 182:1759-1769, 1995
41. Radrizzini M, Accornero P, Amidei A, Aiello A, Delia D, Kurrle D, Colombo MP: IL-12 inhibits apoptosis induced in human TH1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 161:14-21, 1995
42. Chehimi J, Starr SE, Frank I, et al.: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from healthy donors and human immunodeficiency virus-infected patients. J Exp Med 175:787-796, 1992
43. Uherova P, Connick E, McWhinnery S, Schlichtemer, Schooley RT: In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative response from persons infected with human immunodeficiency virus type 1. J Infect Dis 174:483-489, 1996
44. Kohl S, Sigaroudinia M, Charlebois ED, Jacobson MA: Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cells. J Infect Dis 174:1105-1108, 1996
45. Jacobson MA, Hardy D, Connick E, Anderson R, Debruin M: Phase I trial recombinant human interleukin-12 in HIV infected subjects. 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 1996, abstr 309
46. McLeod G, Hammer S: Effects of interleukin (IL)-12 on HIV-1 replication in vitro. First National Conference on Human Retroviruses and Related Infections. Washington, DC, 1993, abstr p 118
47. Mackewicz CE, Ortega H, Levy JA: Effects of cytokines on HIV replication in CD4+ lymphocytes: Lack of identity with the CD8+ cell antiviral factor. Cell Immunol 153:329-336, 1994
48. Foli A, Saville MW, Baseler MW, Yarchoan R: Effects of the TH1 and TH2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 85:2114-2123, 1995